James A Zwiebel

James A Zwiebel

UNVERIFIED PROFILE

Are you James A Zwiebel?   Register this Author

Register author
James A Zwiebel

James A Zwiebel

Publications by authors named "James A Zwiebel"

Are you James A Zwiebel?   Register this Author

23Publications

400Reads

22Profile Views

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.

Cancer Chemother Pharmacol 2011 Apr 3;67(4):927-33. Epub 2010 Jul 3.

Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, Toronto, ON M5G 2M9, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1389-7DOI Listing
April 2011

A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors.

Clin Cancer Res 2009 Oct 29;15(19):6241-9. Epub 2009 Sep 29.

Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845396PMC
October 2009

G3139 (Genasense) in patients with advanced merkel cell carcinoma.

Am J Clin Oncol 2009 Apr;32(2):174-9

Division of Hematology and Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31817eebf8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311264PMC
April 2009

Clinical trials referral resource. Current clinical trials of G3139.

Oncology (Williston Park) 2003 Sep;17(9):1244-6, 1251-3, 1258

Technical Resources International, Inc, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
September 2003

Clinical trials referral resource. Current clinical trials of molecularly targeted agents in children with cancer, Part 2.

Oncology (Williston Park) 2002 Apr;16(4):474, 479-80, 483-4 passim

National Cancer Institute, USA.

View Article

Download full-text PDF

Source
April 2002